Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Europäische Union - Deutsch - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 und 5. 1 für verfügbare daten zu verschiedenen kombinationen).

Sitagliptin-Metformin-Mepha 50/500 mg Filmtabletten Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sitagliptin-metformin-mepha 50/500 mg filmtabletten

mepha pharma ag - metformini hydrochloridum, sitagliptinum - filmtabletten - metformini hydrochloridum 500 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogola, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.025 mg. - diabetes typ 2 - synthetika

Sitagliptin-Metformin-Mepha 50/850 mg Filmtabletten Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sitagliptin-metformin-mepha 50/850 mg filmtabletten

mepha pharma ag - metformini hydrochloridum, sitagliptinum - filmtabletten - metformini hydrochloridum 850 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: lactosum monohydricum 13.7 mg, hypromellosum, e 171, triacetinum, e 172 (rubrum), pro compresso obducto corresp. natrium 1.74 mg. - diabetes typ 2 - synthetika

Sitagliptin-Metformin-Mepha 50/1000 mg Filmtabletten Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sitagliptin-metformin-mepha 50/1000 mg filmtabletten

mepha pharma ag - metformini hydrochloridum, sitagliptinum - filmtabletten - metformini hydrochloridum 1000 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), macrogola, talcum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 2.05 mg. - diabetes typ 2 - synthetika

Metformin Axapharm 500 mg, Filmtabletten Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

metformin axapharm 500 mg, filmtabletten

axapharm ag - metformini hydrochloridum - 500 mg, filmtabletten - metformini hydrochloridum 500 mg, povidonum k 90, magnesii stearas, Überzug: hypromellosum, macrogolum 400, macrogolum 6000 pro compresso obducto. - orales antidiabetikum - synthetika

Metformin Axapharm 850 mg, Filmtabletten Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

metformin axapharm 850 mg, filmtabletten

axapharm ag - metformini hydrochloridum - 850 mg, filmtabletten - metformini hydrochloridum 850 mg, povidonum k 90, magnesii stearas, Überzug: hypromellosum, macrogolum 400, macrogolum 6000 pro compresso obducto. - orales antidiabetikum - synthetika

Metformin Axapharm 1000 mg, Filmtabletten Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

metformin axapharm 1000 mg, filmtabletten

axapharm ag - metformini hydrochloridum - 1000 mg, filmtabletten - metformini hydrochloridum 1000 mg, povidonum k 90, magnesii stearas, Überzug: hypromellosum, macrogolum 400, macrogolum 6000 pro compresso obducto. - orales antidiabetikum - synthetika